ТИРОНЕТ – все о щитовидной железе Для специалистов Журнал Тиронет Архив журнала 2000 год № 4

Субклинические нарушения функции щитовидной железы: оценка практической значимости клинических рекомендаций

Д.С. Купер
David S. Cooper, Division of Endocrinology, Sinai Hospital of Baltimore, Belvedere at Greenspring, Baltimore, MD 21215, USA; www.acponline.org
Cooper D.S. Subclinical thyroid disease: a clinician's perspective. // Ann Intern Med. - 1998 - Vol. 129. - P. 135 - 138.
Впервые русский перевод статьи опубликован в "Журнале международной медицинской практики" (переведена с разрешения ACP - ASIM)
На сервере ТИРОНЕТ публикуется с разрешения редакции "Журнала международной медицинской практики"

ЛИТЕРАТУРА

1. Danese M.D., Powe N., Sawin C.T., Ladenson P.W. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA 1996;276:285-92.
2. Helfand M., Redfern C.C. Screening for thyroid disease: an update. Ann Intern Med 1998;129:144-158.
3. Surks M.I., Chopra I.J., Mariash C.N., Nicoloff J.T., Solomon D.H. American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA 1990;263:1529-32.
4. Glenn G.C. Practice parameter on laboratory panel testing for screening and case finding in asymptomatic adults. Arch Pathol Lab Med 1996;120:929-43.
5. Stott D.J., McLellan A.R., Finlayson J., Chu P., Alexander W.D. Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism. Q J Med 1991;78:77-84.
6. Mudde A.H., Houben A.J., Nieuwenhuijzen Kruseman A.C. Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism. Clin Endocrinol (Oxf) 1994;41:421-4.
7. Faber J., Jensen I.W., Petersen L., Nygaard B., Hegedus L., Siersbaek-Nielsen K. Normalization of serum thyrotrophin by means of radiolodine treatment in subclinical hyperthyroidism: effect on bone loss in postmeno-pausal women. Clin Endocrinol (Oxf) 1998;48:285-90.
8. Sawin C.T., Geller A., Wolf P.A., Belanger A.J., Baker E., Bacharach P., et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994;331:1249-52.
9. Biondi B., Fazio S., Carella C., Amato G., Cittadini A., Lupoli G., et al. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab 1993;77:334-8.
10. Biondi B., Fazio S., Carella C., Sabatini D., Amato G., Cittadini A., et al. Control of adrenergic overactivity by beta-blockade improves quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab 1994;78:1028-33.
11. Shapiro L.E., Sievert R., Ong L., Ocampo E.L., Chance R.A., Lee M., et al. Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine. J Clin Endocrinol Metab 1997;82:2592-5.
12. Figge J., Leinung M., Goodman A.D., Izqueirdo R., Mydosh T., Gates S., et al. The clinical evaluation of patients with subclinical hyperthyroidism and free tniiodothyronine (free T3) toxicosis. Am J Med 1994;96:229-34.
13. Surks M.I., Ocampo E. Subclinical thyroid disease. Am J Med 1996;100:217-23.
14. Marqusee E., Haden S.T. Utiger R.D. Subchnical thyrotoxicosis. Endocrinol Metab Clin North Am 1998;27:37-49.
15. Staub J.J., Althaus B.U., Engler H., Ryff A.S., Trabucco P., Marquardt K., et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992;92:631-41.
16. Zulewski H., Muller B., Exer P., Miserez A.R., Staub J.J. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 1997;82:771-6.
17. Arem R., Escalante D.A., Arem N., Morrisett J.D., Patsch W. Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a). Metabolism 1995;44:1559-63.
18. Kung A.W., Pang R.W., Janus E.D. Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin Endocrinol (Oxf) 1995;43:445-9.
19. Yildirimkaya M., Ozata M., Yilmaz K., Kilinc C., Gundogan M.A., Kutluay T. Lipoprotein(a) concentration in subclinical hypothyroidism before and after levo-thyroxine therapy. Endocr J 1996;43:731-6.
20. Muller B., Zulewski H., Huber P., Ratcliffe J.G., Staub J.J. Impaired action of thyroid hormone associated with smoking in women with hypothyroidism. N Engl J Med 1995;333:964-9.
21. Perk M., O'Neill B.J. The effect of thyroid hormone therapy on angiographic coronary artery disease progression. Can J Cardiol 1997;13:273-6.
22. Monzani F., Del Guerra P., Caraccio N., Pruneti C.A., Pucci E., Luisi M., et al. Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Investig 1993;71:367-71.
23. Centanni M., Cesareo R., Verallo O., Brinelli M., Canettieri G., Viceconti N., et al. Reversible increase of intraocular pressure in subclinical hypothyroid patients. Eur J Endocrinol 1997;136:595-8.
24. Misiunas A., Niepomniszcze H., Ravera B., Faraj G., Faure E. Peripheral neuropathy in subclinical hypothyroidism. Thyroid 1995;5:283-6.
25. Monzani F., Caraccio N., Siciliano G., Manca L., Murri L., Ferrannini E. Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. J Clin Endocrinol Metab 1997;82:3315-8.
26. Rahman Q., Haboubi N.Y., Hudson P.R., Lee G.S., Shah I.U. The effect of thyroxine on small intestinal motility in the elderly. Clin Endocrinol (Oxf) 1991;35:443-6.
27. Arem R., Escalante D. Subclinical hypothyroidism: epidemiology, diagnosis, and significance. Adv Int Med 1996;41:213-50.
28. Singer P.A., Cooper D.S., Levy E.G., Ladenson P.W., Braverman L.E., Daniels G., et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA 1995;273:808-12.